0001576885-23-000052.txt : 20230818 0001576885-23-000052.hdr.sgml : 20230818 20230818183127 ACCESSION NUMBER: 0001576885-23-000052 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230817 FILED AS OF DATE: 20230818 DATE AS OF CHANGE: 20230818 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ives Jeffrey L. CENTRAL INDEX KEY: 0001614096 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40551 FILM NUMBER: 231186938 MAIL ADDRESS: STREET 1: C/O CARA THERAPEUTICS, INC. STREET 2: 1 PARROTT DRIVE CITY: SHELTON STATE: CT ZIP: 06484 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Acumen Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001576885 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 364108129 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 427 PARK ST. CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 BUSINESS PHONE: 925-368-8508 MAIL ADDRESS: STREET 1: 427 PARK ST. CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 4 1 wk-form4_1692397878.xml FORM 4 X0508 4 2023-08-17 0 0001576885 Acumen Pharmaceuticals, Inc. ABOS 0001614096 Ives Jeffrey L. C/O ACUMEN PHARMACEUTICALS, INC. 427 PARK STREET CHARLOTTESVILLE VA 22902 1 0 0 0 1 Common Stock 2023-08-17 4 M 0 39149 0.72 A 39149 D Common Stock 2023-08-17 4 S 0 39149 6.48 D 0 D Common Stock 2023-08-17 4 M 0 2800 1.19 A 2800 D Common Stock 2023-08-17 4 S 0 2800 6.66 D 0 D Stock Option (right to buy) 0.72 2023-08-17 4 M 0 39149 0 D 2029-03-01 Common Stock 39149 0 D Stock Option (right to buy) 1.19 2023-08-17 4 M 0 2800 0 D 2031-01-03 Common Stock 2800 0 D The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on May 17, 2023. The option is fully vested. /s/ Derek Meisner, Attorney-in-Fact 2023-08-18